Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery

[1]  G. Ballantyne.  Peptide YY(1-36) and Peptide YY(3-36): Part II. Changes after Gastrointestinal Surgery and Bariatric Surgery: Part I. Distribution, Release and Actions appeared in the last issue (May 2006) , 2006, Obesity surgery.

[2]  G. Ballantyne.  Peptide YY(1-36) and Peptide YY(3-36): Part I. Distribution, Release and Actions , 2006, Obesity surgery.

[3]  R. Enriquez,et al.  Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity , 2006, Diabetologia.

[4]  E. Jackson,et al.  Pancreatic Polypeptide-Fold Peptide Receptors and Angiotensin II–Induced Renal Vasoconstriction , 2006, Hypertension.

[5]  G. Bray,et al.  Epidemiology, trends, and morbidities of obesity and the metabolic syndrome , 2006, Endocrine.

[6]  M. Roden,et al.  News in gut‐brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery? , 2005, European journal of clinical investigation.

[7]  U. Hanusch-Enserer,et al.  The metabolic syndrome: Effects of a pronounced weight loss induced by bariatric surgery , 2005, Wiener klinische Wochenschrift.

[8]  S. Bloom,et al.  The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension , 2005, Heart.

[9]  B. de Courten,et al.  Pancreatic polypeptide is involved in the regulation of body weight in pima Indian male subjects. , 2004, Diabetes.

[10]  H. Buchwald,et al.  Bariatric Surgery Worldwide 2003 , 2004, Obesity surgery.

[11]  D. Cummings,et al.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  A. Tura,et al.  Improvement of insulin resistance and early atherosclerosis in patients after gastric banding. , 2004, Obesity research.

[13]  M. Laville,et al.  Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. , 2003, The Journal of clinical endocrinology and metabolism.

[14]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[15]  R. Leibel,et al.  To eat or not to eat - how the gut talks to the brain. , 2003, The New England journal of medicine.

[16]  S. Bloom,et al.  Gut and mind , 2003, Gut.

[17]  D. Cummings,et al.  Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? , 2003, The Journal of clinical endocrinology and metabolism.

[18]  T. Alexandrides,et al.  Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. , 2003, Diabetes.

[19]  S Margetic,et al.  Leptin: a review of its peripheral actions and interactions , 2002, International Journal of Obesity.

[20]  S. Woods,et al.  Obesity, diabetes and the central nervous system , 1998, Diabetologia.

[21]  J. Holst,et al.  Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity , 1997, International Journal of Obesity.

[22]  B. Ahrén,et al.  Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets , 1994, Diabetologia.

[23]  P. Mantyh,et al.  Neuropeptide Y/peptide YY receptor binding sites in the heart: Localization and pharmacological characterization , 1993, Neuroscience.

[24]  J. Hegbrant,et al.  Plasma levels of gastrointestinal regulatory peptides in patients receiving maintenance hemodialysis. , 1991, Scandinavian journal of gastroenterology.

[25]  T. Adrian,et al.  Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man. , 1986, The Journal of clinical endocrinology and metabolism.

[26]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[27]  A. Patriti,et al.  Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. , 2007, Annals of surgery.

[28]  L. Kennedy.  Laparoscopic Gastric Banding Prevents Type 2 Diabetes and Arterial Hypertension and Induces Their Remission in Morbid Obesity: A 4-Year Case-Controlled Study , 2006 .

[29]  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. , 1992, The American journal of clinical nutrition.

[30]  A. Parmeggiani,et al.  Human pancreatic polypeptide and somatostatin in chronic renal failure. , 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.

[31]  T. Pappas,et al.  Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. , 1985, The American journal of physiology.